Status:

ACTIVE_NOT_RECRUITING

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

California Institute for Regenerative Medicine (CIRM)

Conditions:

Asymptomatic COVID-19 Infection Laboratory-Confirmed

Symptomatic COVID-19 Infection Laboratory-Confirmed

Eligibility:

All Genders

18+ years

Brief Summary

Plasma from patients who have recovered from coronavirus disease 2019 (COVID-19) is referred to as COVID-19 convalescent plasma (CCP), and may contain antibodies against SARS-CoV-2, the virus responsi...

Detailed Description

PRIMARY OBJECTIVES: I. Establish a testing service for screening prospective donors of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP). II. Characterize the titer and neutralizing prop...

Eligibility Criteria

Inclusion

  • For COVID-19 convalescent individuals:
  • Age: ≥ 18 years
  • Evidence of COVID-19 documented by a laboratory test either by: a diagnostic test (e.g., a NP swab) at the time of illness OR a positive serological test for SARS-CoV-2 antibodies after recovery, if prior diagnostic testing was not performed at the time COVID-19 was suspected.
  • Note: If volunteers can't provide evidence of COVID-19, but are otherwise eligible, then we will test them for SARS-CoV-2 antibodies to confirm eligibility.
  • Be willing to complete a pre-screening questionnaire
  • Be willing to donate blood samples
  • Permit medical record review
  • For prospective CCP donors only: weigh more than 110 pounds and be in general good health
  • For (COVID-19 convalescent plasma (CCP) recipients:
  • Be enrolled in a clinical trial involving the infusion of CCP for the treatment of COVID-19.
  • Be willing to provide blood samples
  • Permit medical record review

Exclusion

    Key Trial Info

    Start Date :

    July 13 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 13 2026

    Estimated Enrollment :

    95 Patients enrolled

    Trial Details

    Trial ID

    NCT04497779

    Start Date

    July 13 2020

    End Date

    October 13 2026

    Last Update

    December 5 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    City of Hope Medical Center

    Duarte, California, United States, 91010

    Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma | DecenTrialz